Brind.

Exagen Inc. appointed Michael Mahler as Chief Scientific Officer on July 29, 2025.

2 reports, 1 independent Updated Jul 29
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Exagen Inc. appointed Michael Mahler as Chief Scientific Officer on July 29, 2025.

Who's involved

What this event is mainly about
Exagen Inc.Michael Mahler

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireExagen Inc. Reports Strong Q2 2025 Results CARLSBAD, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial
  • Unknown outlet